Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Adage Capital Built a New Position in $ADLR

Adage Capital filed on November 16th for its new position in Adolor Corp (ADLR). The SEC 13G filing shows the firm now takes 2.34 million shares in ADLR, corresponding to a 5.03% passive stake ownership. Adage Capital did not have any share in ADLR before, and the firm passed the 5% ownership threshold on November 7th. ADLR skyrocketed on October 24th when Cubist Pharmaceuticals (CBST) signed a definitive agreement to acquire ADLR for $4.25 per shares in cash. Now ADLR has returned nearly 290% since January, and is trading at $4.72 now.

Phill Gross

Other seven hedge funds in our list were bullish about ADLR in the second quarter. Julian Baker And Felix Baker’s Baker Bros. Advisors had the most among the hedge funds, with 6.95 million shares. Jim Simons’ Renaissance Technologies had 2.30 million shares, slightly down by 2% from Q1.

Adage Capital was founded by Phillip Gross in 2001 and is based in Boston. The firm focuses on managing asset for endowments and foundations, including Harvard University, Northwestern University, Dartmouth College.

Per Yahoo! Finance, Adolor Corporation is a biopharmaceutical company engaging “in the discovery, development, and commercialization of novel prescription pain and pain management products.” The company offers ENTEREG (alvimopan), and also a various product candidates in clinical development comprising peripherally-acting mu opioid receptor antagonists ADL5945, ADL6906 (beloxepin). “Its preclinical products include centrally-acting mu opioid receptor antagonists for the treatment of l-DOPA-induced dyskinesia associated with the management of Parkinsons disease.” The company markets its products mainly to wholesale drug distributors. Adolor Corporation was founded in 1993 and is based in Exton, Pennsylvania.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!